AbbVie 2014 Annual Report Download - page 132

Download and view the complete annual report

Please find page 132 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 182

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182

7FEB201503212552 7FEB201503212552
7FEB201503212306 7FEB201503211904 7FEB201503212552
7FEB201503212552 7FEB201503212552
7FEB201503211904 7FEB201503212552
7FEB201503212552 7FEB201503212552
7FEB201503212552 7FEB201503211904
7FEB201503212429 7FEB201503212552 7FEB201503211904
7FEB201503212552 7FEB201503212552
7FEB201503212429 7FEB201503211904 7FEB201503212552 7FEB201503212306
13NOV201221352027
AbbVie directors have backgrounds that when combined provide a portfolio of experience and knowledge that
serve AbbVie’s governance and strategic needs. Director nominees are considered on the basis of a range of criteria
including broad-based business knowledge and relationships, prominence and excellent reputations in their primary fields
of endeavor, as well as a global business perspective and commitment to good corporate citizenship. They must have
demonstrated experience and ability that is relevant to the board’s oversight role with respect to AbbVie’s business and
affairs. Each director’s biography includes the particular experience and qualifications that led the board to conclude that
the director should serve on the board. The directors’ biographies are in the section of this proxy statement captioned
‘‘Information Concerning Director Nominees.’’
Committees of the Board of Directors
................................................................................................................................................................................................................................................................................................................................................................................................
The board of directors has five committees established in AbbVie’s By-Laws: the audit committee, compensation
committee, nominations and governance committee, public policy committee, and executive committee. Each of the
members of the audit committee, compensation committee, nominations and governance committee, and public policy
committee is independent.
R. Alpern
R. Austin
W. Burnside
E. Liddy
E. Rapp
R. Roberts
G. Tilton
F. Waddell
Number of meetings 6344
Lead Director Chairperson Member Financial Expert
Audit Committee
The audit committee is governed by a written charter. This committee assists the board of directors in fulfilling
its oversight responsibility with respect to AbbVie’s accounting and financial reporting practices and the audit process,
the quality and integrity of AbbVie’s financial statements, the independent auditors’ qualifications, independence, and
performance, the performance of AbbVie’s internal audit function and internal auditors, certain areas of legal and
regulatory compliance, and enterprise risk management. Each of the members of the audit committee is financially
literate, as required of audit committee members by the NYSE, and the independence requirements set forth in
Section 10A(m)(3) of the Securities Exchange Act of 1934, as amended (the ‘‘Exchange Act’’). The board of directors has
determined that Ms. Austin, the committee’s chair, is an ‘‘audit committee financial expert.’’
Compensation Committee
The compensation committee is governed by a written charter. This committee assists the board of directors in
carrying out the board’s responsibilities relating to the compensation of AbbVie’s executive officers and directors. The
compensation committee annually reviews the compensation paid to the directors and gives its recommendations to the
full board regarding both the amount of director compensation that should be paid and the allocation of that
12 2015 Proxy Statement
Nominations and
Audit Compensation Governance Public Policy
Committee Committee Committee Committee
THE BOARD OF DIRECTORS AND ITS COMMITTEES